It is unsafe to consume alcohol with Ryzodeg FlexTouch Pen.
CONSULT YOUR DOCTOR
Ryzodeg FlexTouch Pen may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribin...
... Show more
SAFE IF PRESCRIBED
Ryzodeg FlexTouch Pen is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
CAUTION
Ryzodeg FlexTouch Pen should be used with caution in patients with kidney disease. Dose adjustment of Ryzodeg FlexTouch Pen may be needed. Please consult your doctor.
Regular monitoring of blood glucose levels is recommended for dose adjustment.
CAUTION
Ryzodeg FlexTouch Pen should be used with caution in patients with liver disease. Dose adjustment of Ryzodeg FlexTouch Pen may be needed. Please consult your doctor.
Frequent and regular monitoring of blood glucose levels is advised.
Medicine Overview of Ryzodeg FlexTouch Pen 100IU/ml Injection
Introduction
Ryzodeg FlexTouch Pen is a combination of two medicines, a long-acting and a rapid-acting type of insulin used to treat types 1 and 2 diabetes mellitus in both adults and children. It provides a steady level of insulin in the body for an entire day a...
... Show more
Uses of Ryzodeg FlexTouch Pen
Diabetes mellitus (Type 1 & Type 2)
Side effects of Ryzodeg FlexTouch Pen
Common
Rash
Weight gain
Injection site allergic reaction
Lipodystrophy (skin thickening or pits at the injection site)
Edema (swelling)
Itching
Hypoglycemia (low blood glucose level)
How to use Ryzodeg FlexTouch Pen
Your doctor or nurse will guide you how to use this medicine.
How Ryzodeg FlexTouch Pen works
Ryzodeg FlexTouch Pen is a combination of two insulin preparations: Insulin degludec and insulin aspart. Insulin degludec has a prolonged duration of action while insulin aspart has a fast onset of action. Together, they ensure rapid and consistent s...
... Show more
Quick Tips
Take it 15 minutes before a meal or within 20 minutes after starting a meal.
Injection below the skin of the abdomen results in faster absorption as compared to other injection sites such as skin of the upper arms, th...
... Show more
Injection sites must be rotated to prevent hard lumps from developing at one site.
Change to another type or brand of insulin should be done under strict medical supervision as it may require a change in dosage.
Hypoglycemia (low blood sugar level) may occur when taken along with other antidiabetic medicines, alcohol or on delaying/skipping a meal. C...
... Show more
Do not share your insulin device with other people, even if the needle has been changed. You may give other people a serious infection or ge...
... Show more
Opened vials / cartridge are good at room temperature for up to 4 weeks, while unopened vials must be placed in the refrigerator (2°C–8°C).
Brief Description
Indication
Treatment of diabetes mellitus in adults.
Administration
Administer subcutaneously in the upper arm, thigh or abdominal wall. A subcutaneous injection into the abdominal wall results in a faster absorption t...
... Show more
Adult Dose
Subcutaneous
Prefilled pen
Insulin degludec 70 units/insulin aspart 30 units per mL (ie, 100 units/mL for combination)
Starting dose in insulin n...
... Show more
Child Dose
Safety and efficacy not established
Renal Dose
Renal impairment: Dose adjustments may be needed.
Contraindication
Hypersensitivity to the active substances or to any of the excipients.
Mode of Action
Insulin degludec and insulin aspart binds specifically to the human insulin receptor and results in the same pharmacological effects as human insulin....
... Show more
Precaution
Hypoglycaemia
Omission of a meal or unplanned strenuous physical exercise may lead to hypoglycaemia. Hypoglycaemia may occur if the insulin dose is t...
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.